End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
199,000.00 KRW | -1.24% |
|
+4.96% | -6.13% |
11:15am | South Korea's Lee pledges support on trade issues in meet with top conglomerates | RE |
11:15am | South Korea's Lee pledges support on trade issues in meet with top conglomerates | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.74 | 1.88 | 2.51 | 3.51 | 2.86 | |||||
Return on Total Capital | 0.92 | 2.32 | 3.1 | 4.38 | 3.52 | |||||
Return On Equity % | 2.52 | 7.16 | 9.2 | 13.48 | 12.2 | |||||
Return on Common Equity | 1.75 | 5.87 | 8.05 | 12.6 | 11.02 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 17.77 | 18.65 | 19.87 | 20.58 | 20.4 | |||||
SG&A Margin | 14.18 | 11.66 | 11.74 | 9.96 | 10.92 | |||||
EBITDA Margin % | 4.98 | 8.22 | 9.18 | 11.35 | 9.92 | |||||
EBITA Margin % | 2.34 | 5.72 | 6.95 | 9.33 | 8.16 | |||||
EBIT Margin % | 2.3 | 5.68 | 6.89 | 9.3 | 8.13 | |||||
Income From Continuing Operations Margin % | 1.85 | 4.84 | 5.6 | 7.99 | 7.73 | |||||
Net Income Margin % | 1.37 | 4.2 | 5.17 | 7.35 | 7.15 | |||||
Net Avail. For Common Margin % | 1.17 | 3.59 | 4.43 | 6.76 | 6.33 | |||||
Normalized Net Income Margin | 0.82 | 3.61 | 4.42 | 6.66 | 5.98 | |||||
Levered Free Cash Flow Margin | 0.72 | 1 | 2.7 | -0.54 | -3.37 | |||||
Unlevered Free Cash Flow Margin | 0.93 | 1.16 | 2.94 | -0.32 | -3.21 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.52 | 0.53 | 0.58 | 0.6 | 0.56 | |||||
Fixed Assets Turnover | 1.89 | 1.99 | 2.23 | 2.42 | 2.21 | |||||
Receivables Turnover (Average Receivables) | 20.19 | 23.3 | 27.78 | 28.13 | 27.84 | |||||
Inventory Turnover (Average Inventory) | 7.44 | 8.33 | 8.81 | 8.15 | 7.5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.41 | 1.38 | 1.3 | 1.39 | 1.46 | |||||
Quick Ratio | 1.18 | 1.17 | 1.07 | 1.11 | 1.16 | |||||
Operating Cash Flow to Current Liabilities | -0.01 | -0.02 | 0.14 | -0.03 | -0.07 | |||||
Days Sales Outstanding (Average Receivables) | 18.13 | 15.66 | 13.14 | 12.98 | 13.15 | |||||
Days Outstanding Inventory (Average Inventory) | 49.21 | 43.83 | 41.45 | 44.77 | 48.79 | |||||
Average Days Payable Outstanding | 35.37 | 34.12 | 31.16 | 30 | 30.31 | |||||
Cash Conversion Cycle (Average Days) | 31.98 | 25.37 | 23.42 | 27.75 | 31.63 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 120.73 | 131.63 | 124.64 | 123.57 | 131.16 | |||||
Total Debt / Total Capital | 54.7 | 56.83 | 55.48 | 55.27 | 56.74 | |||||
LT Debt/Equity | 81.39 | 90.67 | 83.56 | 89.81 | 100.94 | |||||
Long-Term Debt / Total Capital | 36.88 | 39.15 | 37.2 | 40.17 | 43.67 | |||||
Total Liabilities / Total Assets | 63.53 | 64.69 | 64.46 | 63.96 | 64.6 | |||||
EBIT / Interest Expense | 6.61 | 21.93 | 18.32 | 27.13 | 31.54 | |||||
EBITDA / Interest Expense | 14.84 | 32.41 | 24.4 | 33.59 | 39.21 | |||||
(EBITDA - Capex) / Interest Expense | 1.9 | 18.28 | 16.91 | 20.91 | 21.35 | |||||
Total Debt / EBITDA | 17.14 | 11.02 | 8.66 | 6.72 | 8.91 | |||||
Net Debt / EBITDA | 11.59 | 7.77 | 6.21 | 5.17 | 7.2 | |||||
Total Debt / (EBITDA - Capex) | 133.92 | 19.53 | 12.5 | 10.79 | 16.36 | |||||
Net Debt / (EBITDA - Capex) | 90.53 | 13.78 | 8.95 | 8.31 | 13.22 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.65 | 13.09 | 21.19 | 14.43 | 7.73 | |||||
Gross Profit, 1 Yr. Growth % | 4.68 | 18.66 | 29.13 | 18.44 | 6.76 | |||||
EBITDA, 1 Yr. Growth % | -16.39 | 86.67 | 35.29 | 41.04 | -4.38 | |||||
EBITA, 1 Yr. Growth % | -33.42 | 176.95 | 47.08 | 53.18 | -5.73 | |||||
EBIT, 1 Yr. Growth % | -33.58 | 178.91 | 47.03 | 53.96 | -5.87 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -39.59 | 195.81 | 40.23 | 58.39 | 4.29 | |||||
Net Income, 1 Yr. Growth % | -52.2 | 246.97 | 49.01 | 62.43 | 4.72 | |||||
Normalized Net Income, 1 Yr. Growth % | -65.63 | 398.58 | 48.47 | 68.09 | -3.26 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -51.76 | 247.74 | 50.09 | 65.86 | 0.23 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.16 | 0.71 | 24.62 | 3.17 | 14.37 | |||||
Inventory, 1 Yr. Growth % | -2.83 | 2.75 | 22.72 | 21.76 | 13.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.46 | 13.32 | 3.41 | 7.19 | 27.88 | |||||
Total Assets, 1 Yr. Growth % | 7.63 | 11.75 | 9.32 | 10.45 | 20.3 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.16 | 7.52 | 9.07 | 12.35 | 18.38 | |||||
Common Equity, 1 Yr. Growth % | -0.84 | 7.95 | 9.85 | 12.35 | 17.99 | |||||
Cash From Operations, 1 Yr. Growth % | -197.62 | 187.07 | -1K | -123.7 | 124.78 | |||||
Capital Expenditures, 1 Yr. Growth % | 30.7 | -8.18 | -6.72 | 76.11 | 14.01 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -137.51 | 58.04 | 294.73 | -121.36 | 417.74 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -154.33 | 40.79 | 259.04 | -111.86 | 609.87 | |||||
Dividend Per Share, 1 Yr. Growth % | -25 | 66.67 | 40 | 62.86 | 5.26 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.64 | 5.46 | 17.07 | 17.6 | 11.03 | |||||
Gross Profit, 2 Yr. CAGR % | 10.48 | 11.45 | 23.78 | 23.57 | 12.45 | |||||
EBITDA, 2 Yr. CAGR % | 3.63 | 24.93 | 58.91 | 38.16 | 15.28 | |||||
EBITA, 2 Yr. CAGR % | -0.71 | 35.79 | 101.83 | 50.14 | 20.16 | |||||
EBIT, 2 Yr. CAGR % | -0.57 | 36.1 | 102.5 | 50.49 | 20.39 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.16 | 33.68 | 103.67 | 51.07 | 28.52 | |||||
Net Income, 2 Yr. CAGR % | -2.81 | 28.78 | 127.38 | 55.57 | 30.42 | |||||
Normalized Net Income, 2 Yr. CAGR % | -25.7 | 30.91 | 172.08 | 59.79 | 27.52 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.59 | 29.52 | 128.46 | 60.49 | 28.93 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.83 | -1.24 | 12.03 | 13.39 | 8.62 | |||||
Inventory, 2 Yr. CAGR % | 2.85 | -0.08 | 12.29 | 22.24 | 17.68 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.28 | 7.22 | 8.25 | 5.28 | 17.08 | |||||
Total Assets, 2 Yr. CAGR % | 7.65 | 9.67 | 10.53 | 9.88 | 15.27 | |||||
Tangible Book Value, 2 Yr. CAGR % | 0.93 | 3.09 | 8.29 | 10.7 | 15.33 | |||||
Common Equity, 2 Yr. CAGR % | 1.11 | 3.46 | 8.89 | 11.09 | 15.14 | |||||
Cash From Operations, 2 Yr. CAGR % | -67 | 67.4 | 409.24 | 46.32 | -27.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.54 | 9.55 | -7.45 | 28.17 | 41.7 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -32.39 | -23.01 | 127.4 | -5.51 | 20.31 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -26.97 | -12.54 | 107.62 | -33.04 | 12.95 | |||||
Dividend Per Share, 2 Yr. CAGR % | -13.4 | 11.8 | 52.75 | 51 | 30.93 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.57 | 6.7 | 10.46 | 16.08 | 14.21 | |||||
Gross Profit, 3 Yr. CAGR % | 1.69 | 13.14 | 17.06 | 21.91 | 17.69 | |||||
EBITDA, 3 Yr. CAGR % | -9 | 26.09 | 28.29 | 52.74 | 21.61 | |||||
EBITA, 3 Yr. CAGR % | -19.27 | 39.77 | 39.45 | 84.13 | 28.56 | |||||
EBIT, 3 Yr. CAGR % | -19.41 | 40.23 | 39.65 | 84.86 | 28.71 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -24.91 | 51.26 | 35.83 | 88.99 | 33.51 | |||||
Net Income, 3 Yr. CAGR % | -29.31 | 48.54 | 35.2 | 103.26 | 36.34 | |||||
Normalized Net Income, 3 Yr. CAGR % | -31.03 | 40.15 | 36.52 | 133.49 | 35.17 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -28.6 | 49.89 | 36.04 | 107.67 | 37.18 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.29 | -0.99 | 6.72 | 8.99 | 13.71 | |||||
Inventory, 3 Yr. CAGR % | 3.31 | 2.82 | 7.01 | 15.36 | 19.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.12 | 7.21 | 5.94 | 7.9 | 12.33 | |||||
Total Assets, 3 Yr. CAGR % | 5.52 | 9 | 9.55 | 10.5 | 13.25 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.1 | 3.08 | 5.04 | 9.63 | 13.2 | |||||
Common Equity, 3 Yr. CAGR % | 0.18 | 3.34 | 5.55 | 10.03 | 13.35 | |||||
Cash From Operations, 3 Yr. CAGR % | -52.9 | -32.14 | 193.63 | 83.18 | 68.83 | |||||
Capital Expenditures, 3 Yr. CAGR % | 15.34 | 10.08 | 3.83 | 14.68 | 23.26 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -26.37 | -10.27 | 24.71 | 5.36 | 82.22 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -22.35 | -9.11 | 32.8 | -18.66 | 68.94 | |||||
Dividend Per Share, 3 Yr. CAGR % | -9.14 | 7.72 | 20.51 | 56.05 | 33.89 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.49 | 4.66 | 8.14 | 10.94 | 10.63 | |||||
Gross Profit, 5 Yr. CAGR % | 0.24 | 4.39 | 10.01 | 17.2 | 15.15 | |||||
EBITDA, 5 Yr. CAGR % | -9.14 | 5.5 | 13.73 | 30.79 | 22.93 | |||||
EBITA, 5 Yr. CAGR % | -17.59 | 5.16 | 16.47 | 43.82 | 31.41 | |||||
EBIT, 5 Yr. CAGR % | -17.74 | 5.16 | 16.51 | 44.25 | 31.62 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -21.63 | -0.09 | 11.92 | 51.18 | 33.58 | |||||
Net Income, 5 Yr. CAGR % | -26 | -1.78 | 12.8 | 51.31 | 33.27 | |||||
Normalized Net Income, 5 Yr. CAGR % | -30.39 | 0.31 | 19.42 | 47.7 | 33.45 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -25.55 | -1.16 | 13.69 | 54.04 | 34.06 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.38 | -4.19 | 3.2 | 4.53 | 7.48 | |||||
Inventory, 5 Yr. CAGR % | 4.26 | 2.05 | 6.81 | 10.18 | 11.15 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.61 | 4.37 | 5.14 | 6.44 | 10.26 | |||||
Total Assets, 5 Yr. CAGR % | 4.83 | 5.52 | 7.49 | 9.35 | 11.8 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.32 | 2.11 | 3.3 | 6.06 | 9.04 | |||||
Common Equity, 5 Yr. CAGR % | 2.3 | 2.23 | 3.58 | 6.37 | 9.28 | |||||
Cash From Operations, 5 Yr. CAGR % | -19.97 | 3.37 | 22.06 | -7.72 | 68.26 | |||||
Capital Expenditures, 5 Yr. CAGR % | -10.45 | 7.7 | 5.62 | 16.99 | 17.58 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -30.04 | 17.48 | 15.59 | -11.77 | 24.35 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -25.68 | 30.89 | 15.08 | -22.09 | 25.75 | |||||
Dividend Per Share, 5 Yr. CAGR % | -5.59 | 4.56 | 11.84 | 23.3 | 24.57 |
- Stock Market
- Equities
- A005380 Stock
- Financials Hyundai Motor Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition